This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovator Spotlight: Richard A. Tschirret-Guth
Introduction: Richard A. Tschirret-Guth is an accomplished inventor based in Lawrenceville, NJ, known for his substantial contributions to pharmacology. With a focus on neurokinin research, he has developed innovative compounds that hold promise in treating various medical conditions. His work exemplifies the intersection of scientific inquiry and practical application, highlighting the importance of patents in advancing medical therapies.
Latest Patents: Tschirret-Guth holds a patent for "Hydroisoindoline tachykinin receptor antagonists." This invention relates to specific hydroisoindoline compounds that function as neurokinin-1 (NK-1) receptor antagonists. These compounds serve as inhibitors of tachykinin, particularly substance P, and have potential applications in pharmaceutical formulations for treating disorders such as emesis, urinary incontinence, depression, and anxiety.
Career Highlights: Richard A. Tschirret-Guth currently works with Merck Sharp & Dohme Corporation, a well-respected leader in the global pharmaceutical industry. His research reflects a deep commitment to enhancing therapeutic options for patients affected by debilitating conditions. Tschirret-Guth's single patent is a testament to his innovative thinking and dedication to advancing medical knowledge.
Collaborations: Throughout his career, Richard has collaborated with esteemed colleagues such as Jinlong Jiang and Robert J. DeVita. These partnerships have enriched his research endeavors and contributed to the robust development of his patented inventions. Teamwork in the research environment fosters creativity and leads to breakthrough discoveries aimed at improving health outcomes.
Conclusion: Richard A. Tschirret-Guth's work as an inventor is impactful and critical to the field of pharmacology. His patent on hydroisoindoline tachykinin receptor antagonists illustrates not only his innovative prowess but also the significance of patents in protecting and promoting scientific advancements. As he continues his work at Merck Sharp & Dohme Corporation, Tschirret-Guth remains a key figure in developing new treatments for complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile